Elizabeth Glaser Pediatric Aids Foundation
88% goes to programs $3 to raise $100 Thin reserves Declining revenue
Elizabeth Glaser Pediatric Aids Foundation is a 501(c)(3) organization based in Washington, District of Columbia, registered in 1989, with $138,028,470 in FY2024 revenue. CharityIndex grades it B+, and it directs about 88% of spending to programs.
1120 19th St Nw Ste 500, Washington, DC, 20036 EIN 95-4191698 Since 1989
Revenue (FY2024)
$138.0M
▼ 15.0% vs prior year
Medical Research median: $217K
Expenses (FY2024)
$140.0M
Net assets
$8.6M
Employees
135
CharityIndex rating
One independent A+ to F grade from four published criteria, each scored separately from IRS filings and combined by weight.
B+
★★★★
Rated on 4 of 4 criteria.
Held down by its weakest criterion — a strong score on one criterion can't hide a weak one.
How the rating works →AProgram efficiency40% of the rating88% to programs · $3 to raise $100
Measures how much of every dollar spent actually reaches programs, plus what it costs to raise $100 of donations. The worse of the two measures sets the letter (85%+ to programs is an A; under $15 to raise $100 is an A), averaged over the three most recent filings. For Elizabeth Glaser Pediatric Aids Foundation: 88% to programs · $3 to raise $100 earns a A on this criterion. See the exact thresholds →
C+Financial health25% of the rating1 mo reserves · -1% margin
Measures whether the organization is built to last: how many months its reserves would cover expenses (3+ months earns an A-range score, but hoarding 5+ years of budget is capped) and whether it runs a surplus or a deficit. For Elizabeth Glaser Pediatric Aids Foundation: 1 mo reserves · -1% margin earns a C+ on this criterion. See the exact thresholds →
A+Governance25% of the rating6 of 6 checks met
Checks how the organization is run, from its own Form 990: an independent board majority, a board of five or more, conflict-of-interest, whistleblower and document-retention policies, and independently audited financials. The share of disclosed checks that pass sets the letter. For Elizabeth Glaser Pediatric Aids Foundation: 6 of 6 checks met earns a A+ on this criterion. See the exact thresholds →
A+Transparency10% of the rating5 of 5 disclosure signals
Counts five disclosure signals: a recent filing, a mission statement, program descriptions, a listed website, and the full expense breakdown. More disclosure, better letter. For Elizabeth Glaser Pediatric Aids Foundation: 5 of 5 disclosure signals earns a A+ on this criterion. See the exact thresholds →
Show this grade on your website
A live seal — it updates automatically when the grade changes and links donors to this verified profile.
Mission
The elizabeth glaser pediatric aids foundation seeks to end hiv/aids globally in children, youth, and families.
What they do
Egpaf plays a critical role in both defining the pediatric aids research agenda and supporting and conducting research to improve the lives of women, youth, and families affected by hiv. egpaf leads studies in clinical, laboratory, and implementations science research. its focus is optimizing health service delivery; building an evidence base for new and innovative interventions; and effectively scaling up promising hiv and maternal, newborn, and child health interventions.
Egpaf's public policy and advocacy team builds on elizabeth glaser's legacy of fighting for the best policies for women, youth, and families living with and affected by hiv. with staff on three continents, egpaf is well positioned to champion children's rights in several realms-including those of national governments, african regional bodies, and multilateral organizations-to produce victories for children and adolescents.
Contact & location
- Address
- 1120 19th St Nw Ste 500, Washington, DC, 20036
- City
- Washington
- State
- District of Columbia
- Category
- Medical Research
- Subcategory
- Organ Research
- Phone
- …
- Website
- …
Financial trends
Revenue grew from $119.2M (FY2013) to $138.0M (FY2024) across 12 reported years.
Financial snapshot
Financial health & position (FY2024)
Liabilities $29.1MNet assets $8.6M
Operating margin
-1.4%
Spent more than it raised in the latest fiscal year.
Total assets
$37.7M
Total liabilities
$29.1M
Net assets
$8.6M
Salaries & benefits
$76.3M
54% of expenses
Board members
14
13 independent
Financials by year
| Fiscal year | Revenue | Expenses | Net assets | Total assets | Form |
|---|---|---|---|---|---|
| 2024 | $138,028,470▼15.0% | $140,023,453▼13.8% | $8,610,030▼8.7% | $37,738,225▼9.4% | 990 |
| 2023 | $162,295,489▼5.9% | $162,458,737▼5.6% | $9,433,344▲5.5% | $41,655,184▼1.7% | 990 |
| 2022 | $172,481,008▼8.1% | $172,087,793▼7.0% | $8,938,659▼11.5% | $42,359,587▲16.8% | 990 |
| 2021 | $187,687,168▲13.6% | $185,043,941▲10.1% | $10,100,445▲39.2% | $36,264,265▲8.6% | 990 |
| 2020 | $165,216,570▼18.3% | $168,062,128▼16.4% | $7,255,301▼26.1% | $33,395,440▼10.7% | 990 |
| 2019 | $202,227,730▲1.2% | $201,028,105▲0.6% | $9,821,441▲19.6% | $37,379,584▼0.6% | 990 |
| 2018 | $199,909,040▲10.8% | $199,862,241▲11.0% | $8,209,064▼2.8% | $37,610,250▼4.8% | 990 |
| 2017 | $180,487,409▲25.8% | $180,014,269▲26.3% | $8,449,826▲9.6% | $39,508,407▲20.0% | 990 |
| 2016 | $143,494,416▲18.9% | $142,583,831▲18.2% | $7,707,695▲15.5% | $32,921,840▲12.7% | 990 |
| 2015 | $120,699,012▼4.3% | $120,658,812▼4.4% | $6,674,059▼0.7% | $29,216,175▲29.6% | 990 |
| 2014 | $126,056,619▲5.8% | $126,187,776▲3.9% | $6,724,023▼10.0% | $22,549,204▲0.2% | 990 |
| 2013 | $119,164,859 | $121,432,406▼1.8% | $7,471,883▼21.7% | $22,514,577▼0.6% | 990 |
| 2012 | — | $123,634,170▼24.7% | $9,545,158▼17.6% | $22,642,164▼32.0% | 990 |
| 2011 | — | $164,151,044▲13.7% | $11,583,246▼17.6% | $33,317,641▼8.7% | 990 |
| 2010 | — | $144,428,772 | $14,048,956 | $36,506,742 | 990 |
Original Form 990 PDFs (the Form column) are served by ProPublica Nonprofit Explorer, as filed with the IRS. Create a free account to download the CSV report.
Leadership & compensation (FY2024)
Highest-paid: Charles J Lyons II — $591,104 (0.42% of total expenses)
| Name | Title | Hours/week | Compensation |
|---|---|---|---|
| Charles J Lyons II | President & Ceo | 40 | $591,104 |
| Patricia Devine Karlin | Evp, External Affairs & Business Development | 40 | $344,497 |
| Adriaantje Giphart | Evp, Medical & Scientific Affairs | 40 | $335,929 |
| Craig Molyneaux | Chief Operating Officer | 40 | $318,352 |
| Douglas Horner | Vp, Awards, Compliance & Operational Excellence | 40 | $281,544 |
| Allan Ahimbisibwe | Chief of Party, Malawi | 40 | $273,000 |
| Appolinaire Tiam | Vice President, Technical Strategy & Innovation | 40 | $266,795 |
| Sherian Abramaitys-yi | Chief Human Resources Officer | 40 | $255,176 |
| Veena Sampathkumar | Country Director, Malawi | 40 | $250,475 |
| Shabbir Ismail Argaw | Senior Director, Strategic Information | 40 | $241,625 |
| Roland Van De Ven | Technical Director, Tanzania | 40 | $235,570 |
| Catherine Connor | Vp, Public Policy & Advocacy | 40 | $229,585 |
| Yolanda Brignoni | Vp, External Affairs | 40 | $228,429 |
| Aida Yemane--berhan | Sr Director, Disease Prevention & Management | 40 | $217,298 |
| Jill Mathis | Vp, New Business Development | 40 | $213,186 |
| Paul Fisher | Chief Development Officer | 40 | $212,061 |
| Pauline Devinger | Sr Director, Internal Audit & Risk Management | 40 | $209,820 |
| Mahoudo Bonou | Technical Director, Mozambique | 40 | $192,445 |
| Caspian Chouraya | Country Director, Swaziland | 40 | $184,916 |
| Ameenah Salaam | Board Member (as of 11/23) | 0.5 | — |
Top vendors & contractors (FY2024)
| Contractor | Services | Paid |
|---|---|---|
| Amref Health Africa | Program Service Support | $934,208 |
| Unit4 Business Software Inc | Program Service Support | $747,685 |
| Engenderhealth Inc | Program Service Support | $472,481 |
| Microsoft Corporation | Program Service Support | $400,237 |
| The George Washington University | Program Service Support | $398,405 |
Grants received · $43.9M total
96 grants to Elizabeth Glaser Pediatric Aids Foundation totaling $43.9M, reported by foundations on their Schedule I filings — showing the 15 most recent.
| Grantmaker | Purpose | Year | Amount |
|---|---|---|---|
| Gavi Alliance | Partner support | 2024 | $521,195 |
| Clinton Health Access Initiative Inc | Health | 2024 | $180,697 |
| American Online Giving Foundation Inc | General support | 2024 | $24,543 |
| Paypal Charitable Giving Fund | General support | 2024 | $5,562 |
| Johns Hopkins University | Sub-award | 2023 | $529,996 |
| Fidelity Investments Charitable Gift Fund | For grant recipient's exempt purposes | 2023 | $128,570 |
| Associated Students Ucla | Ped hiv/ aids research | 2023 | $44,597 |
| American Online Giving Foundation Inc | General support | 2023 | $25,849 |
| National Philanthropic Tr | Religion | 2023 | $10,850 |
| The Pittsburgh Foundation | Aids | 2023 | $10,000 |
| George Washington University | Subaward | 2023 | $5,335 |
| Clinton Health Access Initiative Inc | Health | 2022 | $1,218,516 |
| Clinton Health Access Initiative Inc | Health | 2022 | $1,218,516 |
| Fidelity Investments Charitable Gift Fund | For grant recipient's exempt purposes | 2022 | $274,376 |
| Johns Hopkins University | Sub-award | 2022 | $92,510 |
Grants made · $236K in FY2024
1 grant totaling $236K in FY2024. All grants made by Elizabeth Glaser Pediatric Aids Foundation →
| Recipient | Purpose | Amount |
|---|---|---|
| No Means No Worldwide | Providing prevention of mother to child transmission (pmtct) and care & treatment services to children and families afflicted with hiv/ aids as well as monitoring of the use of all grant funds sent to foreign organizations. | $235,936 |
Similar organizations in Medical Research
Medical Research
Childrens Research Institute
Washington, DC
$102.1M
Cannual revenue
Medical Research
Paralyzed Veterans of America
Washington, DC
$86.4M
C+annual revenue
Medical Research
Society For Neuroscience
Washington, DC
$36.7M
Bannual revenue
Medical Research
Alliance For Regenerative Medicine
Washington, DC
$18.4M
Bannual revenue
Medical Research
Asn Foundation For Kidney Research
Washington, DC
$14.2M
Bannual revenue
Medical Research
American Cancer Society Cancer Action Network Inc
Washington, DC
$11.5M
Bannual revenue
Medical Research
Usagainstalzheimers
Washington, DC
$10.5M
Bannual revenue
Medical Research
American Journal of Preventive Medicine
Washington, DC
$8.1M
Bannual revenue
Medical Research
Surgeons Data Science Collective Inc
Washington, DC
$7.9M
Bannual revenue
Medical Research
Friends of Cancer Research
Washington, DC
$7.5M
Bannual revenue
Compare Elizabeth Glaser Pediatric Aids Foundation
Frequently asked questions
- Is Elizabeth Glaser Pediatric Aids Foundation a legitimate nonprofit?
- Yes. Elizabeth Glaser Pediatric Aids Foundation is a 501(c)(3) organization registered with the U.S. Internal Revenue Service under EIN 95-4191698, based in Washington, District of Columbia. Donations are tax-deductible.
- What is Elizabeth Glaser Pediatric Aids Foundation's EIN?
- Elizabeth Glaser Pediatric Aids Foundation's Employer Identification Number (EIN) is 95-4191698.
- How much revenue does Elizabeth Glaser Pediatric Aids Foundation report?
- Elizabeth Glaser Pediatric Aids Foundation reported $138,028,470 in total revenue on its fiscal year 2024 IRS Form 990 filing.
- How much of Elizabeth Glaser Pediatric Aids Foundation's spending goes to programs?
- Elizabeth Glaser Pediatric Aids Foundation spends about 88% of its total expenses on programs, based on its latest IRS Form 990.
- What financial grade does Elizabeth Glaser Pediatric Aids Foundation have?
- CharityIndex grades Elizabeth Glaser Pediatric Aids Foundation B+, based on program efficiency and fundraising cost.
- How much does Elizabeth Glaser Pediatric Aids Foundation's highest-paid employee make?
- The highest reported compensation on Elizabeth Glaser Pediatric Aids Foundation's latest Form 990 is $591,104, paid to Charles J Lyons II (President & Ceo).
More nonprofits in Washington
Explore more
Data for Elizabeth Glaser Pediatric Aids Foundation (EIN 95-4191698) comes from the IRS Business Master File and e-filed Form 990 returns, via CharityIndex. Figures reflect what the organization reported to the IRS for each fiscal year.